Effects of the Capsular Polysaccharides of Cryptococcus neoformans on Phagocyte Migration and Inflammatory Mediators [General Articles]
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
253-266
Author(s):
Pauline M. Ellerbroek, M. E. Annemiek, Walenkamp, Andy I.M. Hoepelman and Frank E.J. Coenjaerts
Targets of Antidementive Therapy: Drugs with a Specific Pharmacological Mechanism of Action
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
223-229
Author(s):
Lutz Frolich, Johannes Fox, Frank Padberg, Konrad Maurer, Hans-Jurgen Moller and Harald Hampel
Economic Aspects on Drug Therapy of Dementia
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
295-301
Author(s):
Wimo A. and Winblad B.
Angiogenesis Inhibitors: Current & Future Directions
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1-9
Author(s):
Shaker A. Mousa and Ahmed S. Mousa
Angiogenesis: A Target for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
11-26
Author(s):
Giampaolo Tortora, Davide Melisi and Fortunato Ciardiello
Antiangiogenic Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
27-37
Author(s):
Daniel Albo, Thomas N. Wang and George P. Tuszynski
Resistance to Anti-VEGF Agents
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
51-64
Author(s):
Ton N. C. and Jayson G. C.
Subject Index to Volume 9
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
89-108
Author(s):
Bentham Science Publishers
Neuropharmacology of Cannabinoid System: From Basic Science to Clinical Applications
Journal:
Current Neuropharmacology
Volume:
2
Page:
1-7
Author(s):
F. R. Buttarelli, F. R. Patacchioli, G. Palladini, E. Brunetti and F. E. Pontieri
Metabolic Fate of Endocannabinoids
Journal:
Current Neuropharmacology
Volume:
2
Page:
37-48
Author(s):
Mario van der Stelt and Vincenzo Di Marzo